Chidamide as maintenance after chemotherapy or hematopoietic stem cell transplantation in 27 children with T-cell lymphoblastic leukemia: A real-world prospective study

Chidamide as maintenance after chemotherapy or hematopoietic stem cell transplantation in 27 children with T-cell lymphoblastic leukemia: A real-world prospective study

BackgroundThe long-term overall survival of children with T-cell acute lymphoblastic leukemia (T-ALL) is limited to approximately 80–85% because of a high incidence of relapse after achieving remission with intensive chemotherapy and hematopoietic stem cell transplantation (HSCT). Novel treatment st...

Full description

Bibliographic Details
Main Authors:	Xin-Yu Li, Xia-Wei Han, Ke Huang, Ya-Ting Zhang, Hong-Gui Xu, Dun-Hua Zhou, Lu-Hong Xu, Jian-Pei Fang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Medicine
Subjects:	Chidamide T-cell acute lymphoblastic leukemia children chemotherapy hematopoietic stem cell transplantation
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1096529/full

Similar Items

Therapeutic Interaction of Apatinib and Chidamide in T-Cell Acute Lymphoblastic Leukemia through Interference with Mitochondria Associated Biogenesis and Intrinsic Apoptosis
by: Mengya Zhong, et al.
Published: (2021-09-01)

Comparison of Chemotherapy Combined With Chidamide Versus Chemotherapy in the Frontline Treatment for Peripheral T-Cell Lymphoma
by: Jinni Wang, et al.
Published: (2022-02-01)

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
by: Yuankai Shi, et al.
Published: (2017-03-01)

Comparison of chemotherapy and chidamide combined with chemotherapy in patients with untreated angioimmunoblastic T-cell lymphoma
by: Simeng Gu, et al.
Published: (2024-04-01)

Acute and Persistent Remission of Aggressive Natural Killer Cell Leukemia in an Older Patient Induced by Chidamide Combined with Cyclophosphamide, Vindesine, Prednisone, and Etoposide Therapy
by: Qingqing Lin, et al.
Published: (2023-08-01)

Chidamide modulates proliferation, migration and apoptosis of human tongue squamous carcinoma SCC9 cells through multiple signaling pathways
by: Huang Hongyao, et al.
Published: (2021-01-01)

Synthesis and Crystal Structure Analysis of Histone Deacetylase Inhibitor Chidamide
by: Bo Han, et al.
Published: (2023-06-01)

Circulating PD‐1 (+) cells may participate in immune evasion in peripheral T‐cell lymphoma and chidamide enhance antitumor activity of PD‐1 (+) cells
by: Wei Zhang, et al.
Published: (2019-05-01)

A Novel Mechanism of Action of Histone Deacetylase Inhibitor Chidamide: Enhancing the Chemotaxis Function of Circulating PD-1(+) Cells From Patients With PTCL
by: Chong Wei, et al.
Published: (2021-06-01)

A novel conditioning regimen of chidamide, cladribine, gemcitabine, and busulfan in the autologous stem cell transplantation of aggressive T-cell lymphoma
by: Qiang Zeng, et al.
Published: (2023-03-01)

Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells
by: Haijun Zhao, et al.
Published: (2022-05-01)

The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
by: Wei Zhang, et al.
Published: (2021-08-01)

Vemurafenib combined with chidamide promotes senescence of secondary acute myeloid leukemia cells
by: ZHOU Qiao, et al.
Published: (2023-08-01)

Maintenance therapy with chidamide prevents from postoperative recurrence after autologous hematopoietic stem cell transplantation for peripheral T cell lymphoma
by: LIU Hongyun, et al.
Published: (2020-09-01)

Successful Treatment of Chidamide and Cyclosporine for Refractory/Relapsed Angioimmunoblastic T Cell Lymphoma With Evans Syndrome: A Case Report With Long-Term Follow-Up
by: Fang Zhu, et al.
Published: (2020-08-01)

Identification of potential target genes of breast cancer in response to Chidamide treatment
by: Han Han, et al.
Published: (2022-11-01)

LncRNA ENST869 Targeting Nestin Transcriptional Region to Affect the Pharmacological Effects of Chidamide in Breast Cancer Cells
by: Xiuyan Feng, et al.
Published: (2022-04-01)

Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide
by: Jinghong Chen, et al.
Published: (2023-02-01)

Chidamide enhances cytotoxicity of doxorubicin by promoting autophagy and apoptosis in breast cancer
by: Jieqing Li
Published: (2023-04-01)

Chidamide combined with mycophenolate mofetil suppress proliferation of secondary acute myeloid leukemia cells
by: CAI Duo, et al.
Published: (2022-07-01)

Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells
by: Yin Li, et al.
Published: (2017-08-01)

Chidamide plus envafolimab as subsequent treatment in advanced non‐small cell lung cancer patients resistant to anti‐PD‐1 therapy: A multicohort, open‐label, phase II trial with biomarker analysis
by: Yaxiong Zhang, et al.
Published: (2024-04-01)

Chidamide Combined With Doxorubicin Induced p53-Driven Cell Cycle Arrest and Cell Apoptosis Reverse Multidrug Resistance of Breast Cancer
by: Lixia Cao, et al.
Published: (2021-03-01)

Chidamide and Oxaliplatin Synergistically Inhibit Colorectal Cancer Growth by Regulating the RPS27A-MDM2-P53 Axis
by: Li Z, et al.
Published: (2023-08-01)

Chidamide Reverses Fluzoparib Resistance in Triple-Negative Breast Cancer Cells
by: Xinyang Li, et al.
Published: (2022-02-01)

Chidamide improves gefitinib treatment outcomes in NSCLC by attenuating recruitment and immunosuppressive function of myeloid-derived suppressor cells
by: Jinjin Shao, et al.
Published: (2024-04-01)

Chidamide Maintenance Therapy Following Induction Therapy in Patients With Peripheral T-Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation: Case Series From China
by: Wei Guo, et al.
Published: (2022-06-01)

Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia
by: Xuejie Jiang, et al.
Published: (2021-03-01)

Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma
by: Mengya Zhong, et al.
Published: (2021-12-01)

The role of chidamide in the treatment of B-cell non-Hodgkin lymphoma: An updated systematic review
by: Hastono Ridwansyah, et al.
Published: (2023-09-01)

Prognostic value and outcome for acute lymphocytic leukemia in children with MLL rearrangement: a case-control study
by: Kun-yin Qiu, et al.
Published: (2022-12-01)

Chidamide-based 3-drug combination regimen reverses molecular relapse post transplantation in AML1-ETO–positive acute myeloid leukemia
by: Yang Xi, et al.
Published: (2023-01-01)

Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia
by: Pei-Jie Shi, et al.
Published: (2016-02-01)

Clinical Profile and Induction Outcome of Children with T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma
by: Awais Arshed, et al.
Published: (2022-11-01)

Network Pharmacology and Experimental Validation Reveal the Effects of Chidamide Combined With Aspirin on Acute Myeloid Leukemia-Myelodysplastic Syndrome Cells Through PI3K/AKT Pathway
by: Simin Liang, et al.
Published: (2021-09-01)

Chidamide acts on the histone deacetylase‐mediated miR‐34a/Bcl‐2 axis to regulate NB4 cell line proliferation and apoptosis
by: Jie Peng, et al.
Published: (2020-12-01)

Chidamide Enhances the Cytotoxicity of Cytarabine and Sorafenib in Acute Myeloid Leukemia Cells by Modulating H3K9me3 and Autophagy Levels
by: He Huang, et al.
Published: (2019-12-01)

Targeted treatment of T-cell acute lymphoblastic leukemia: latest updates from the 2022 ASH Annual Meeting
by: Jieyu Xu, et al.
Published: (2023-03-01)

CAG regimen for refractory or relapsed adult T‐cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study
by: Jie‐Jing Qian, et al.
Published: (2020-08-01)

Precursor B-cell lymphoblastic leukemia of the arm mimicking neurogenic tumor: case report
by: Sui Xiu-fang, et al.
Published: (2012-07-01)